A study on Ayurvedic etiopathology and treatment of Bronchial Asthma and effect of shwasahara drugs in the management of Bronchial asthma and Cardiac Asthma
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: J454- Moderate persistent asthmaHealth Condition 2: J454- Moderate persistent asthma
- Registration Number
- CTRI/2021/04/032624
- Lead Sponsor
- Dr Roopa M R
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.subjects with the diagnosed case of Bronchial Asthma
2.For Bronchial Asthma age group of 18 to 60yrs
3.subjects with the diagnosed case of cardiac Asthma (LVF, EF-35-39%)
4.For Bronchial Asthma age group of 40 to 60yrs
Exclusion Criteria
1.severe life-threatening type of Bronchial Asthma (status Asthmatics)associated with Complications.
2.severe life-threatening type of LVF (ejection fraction less than 35%)associated with Complications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of Dyspnea , quality of life improvement <br/ ><br> <br/ ><br>Timepoint: 4weeks <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method Relive of other symptoms of ShwasaTimepoint: 30 days